Neovasc (NVCN) Granted FDA Approval to Initiate Pivotal Reducer Trial

November 6, 2017 7:13 AM

Neovasc Inc. (NASDAQ: NVCN) announced that it has received approval of the U.S. Food and Drug Administration ("FDA") to initiate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found